August 28, 2013 at 13:16 PM EDT
Durect Corporation (DRRX) - Product Pipeline Analysis, 2013 Update: New Research Report Available at Fast Market Research
Boston, MA -- (SBWIRE) -- 08/28/2013 -- DURECT Corporation (Durect) is a pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. Currently, the company markets two products, namely, Alzet osmotic pump and Lactel biodegradable polymer. The company's product pipeline consists of several investigational drug candidates in clinical development. Durect has five drug delivery technology platforms: SABER, CLOUD, ORADUR, TRANSDUR and DURIN biodegradable implant. The company operates in North America, Europe and Asia.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here